Literature DB >> 3010015

Clinical characterization of imuthiol.

E Lemarie, M Musset, C Charbonnier, M Renoux, G Renoux.   

Abstract

Imuthiol is a nontoxic agent recruting and regulating T cells. Phase III studies in chronic bronchitis and bronchiectasis showed that immune functions were restored to normal, or near normal values. Cure was obtained in rheumatoid arthritis, tuberculosis and chronic infections in the elderly. Imuthiol is an effective agent for the treatment of syndromes and disease states where the underlying defect is a T-cell deficiency or dysfunction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010015

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  1 in total

1.  Decreased counts of blood neutrophils, monocytes, and platelets in human immunodeficiency virus-infected children and young adults treated with diethyldithiocarbamate.

Authors:  J L Shenep; W T Hughes; P M Flynn; P K Roberson; F G Behm; G H Fullen; S G Kovnar; K P Guito; T O Brodkey
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.